Fil LTD Surface Oncology, Inc. Transaction History

Fil LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$1.57 - $6.56 $1.02 Million - $4.25 Million	-647,317 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.75 - $4.89 $16,786 - $29,848	6,104 Added 0.95%	647,317 $1.83 Million
Q1 2019 May 13, 2019	SELL	$4.11 - $5.88 $1.35 Million - $1.93 Million	-328,880 Reduced 33.9%	641,213 $3.06 Million
Q4 2018 Feb 13, 2019	BUY	$3.65 - $10.69 $304,326 - $891,300	83,377 Added 9.4%	970,093 $4.11 Million
Q2 2018 Aug 10, 2018	BUY	$12.83 - $17.41 $11.4 Million - $15.4 Million	886,716 New	886,716 $14.5 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.